1. Sex-based differences in nuclear medicine imaging and therapy

   • Riemer H. J. A. Slart
   • Lioe-Fee de Geus-Oei
   • Paola A. Erba

   Letter to the Editor 12 January 2023 Pages: 971 - 974

   

2. Preoperative stratification of cytologically indeterminate thyroid nodules by [¹⁸F]FDG-PET: can Orpheus bring back Eurydice?

   • Dennis Vriens
   • Elizabeth J. de Koster
   • For the EfFECTS trial consortium

   Letter to the Editor 20 January 2023 Pages: 975 - 979

3. EANM practice guideline for quantitative SPECT-CT

   • John C. Dickson
   • Ian S. Armstrong
   • Ken Herrmann

   Guidelines Open access 05 December 2022 Pages: 980 - 995

   

4. Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)

   • Estel Collado Camps
   • Sanne A. M. van Lith
   • Martin Gotthardt

   Original Article Open access 30 November 2022 Pages: 996 - 1004

   

5. ^99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types

   • Betül Altunay
   • Andreas Goedicke
   • Felix M. Mottaghy

   Original Article Open access 09 December 2022 Pages: 1005 - 1013

   

6. Current research topics in FAPI theranostics: a bibliometric analysis

   • Andor F. van den Hoven
   • Ruth G. M. Keijsers
   • Jules Lavalaye

   Review Article 28 November 2022 Pages: 1014 - 1027

   

7. Multi-center, multi-vendor validation of deep learning-based attenuation correction in SPECT MPI: data from the international flurpiridaz-301 trial

   • Tomoe Hagio
   • Jonathan B. Moody
   • Venkatesh L. Murthy

   Short Communication 19 November 2022 Pages: 1028 - 1033

   

8. Decentralized collaborative multi-institutional PET attenuation and scatter correction using federated deep learning

   • Isaac Shiri
   • Alireza Vafaei Sadr
   • Habib Zaidi

   Original Article Open access 12 December 2022 Pages: 1034 - 1050

   

9. In vivo methods for imaging blood–brain barrier function and dysfunction

   • William James Harris
   • Marie-Claude Asselin
   • Ben Robert Dickie

   Review Article Open access 28 November 2022 Pages: 1051 - 1083

   

10. Brain ¹⁸F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics

    • François Goehringer
    • Alexandra Bruyere
    • Antoine Verger

    Short Communication 02 November 2022 Pages: 1084 - 1089

    

11. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)

    • Francesco Lanfranchi
    • Dario Arnaldi
    • Silvia Morbelli

    Original Article 06 December 2022 Pages: 1090 - 1102

    

12. The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies

    • Moath Said Alfawara
    • Ahmed Ibrahim Ahmed
    • Mouaz H. Al-Mallah

    Original Article 07 December 2022 Pages: 1103 - 1110

    

13. Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications

    • Zhongquan Cheng
    • Jiaojiao Ma
    • Yang Du

    Review Article 29 November 2022 Pages: 1111 - 1133

    

14. [¹⁸F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [¹²³I] MIBG in neural crest tumour patients

    • Elin Pauwels
    • Sofie Celen
    • Christophe M. Deroose

    Original Article 26 November 2022 Pages: 1134 - 1145

    

15. [¹⁸F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study

    • Atia Samim
    • Thomas Blom
    • Bart de Keizer

    Original Article Open access 12 December 2022 Pages: 1146 - 1157

    

16. Application of the long axial field-of-view PET/CT with low-dose [¹⁸F]FDG in melanoma

    • Christos Sachpekidis
    • Leyun Pan
    • Antonia Dimitrakopoulou-Strauss

    Original Article Open access 07 December 2022 Pages: 1158 - 1167

    

17. Phantom-based evaluation of yttrium-90 datasets using biograph vision quadra

    • Konstantinos G. Zeimpekis
    • Lorenzo Mercolli
    • Axel Rominger

    Original Article Open access 12 December 2022 Pages: 1168 - 1182

    

18. Glioblastoma PET/MRI: kinetic investigation of [¹⁸F]rhPSMA-7.3, [¹⁸F]FET and [¹⁸F]fluciclovine in an orthotopic mouse model of cancer

    • Marcel Lindemann
    • Ana Oteiza
    • Mathias Kranz

    Original Article Open access 22 November 2022 Pages: 1183 - 1194

    

19. Efficacy and safety of peptide receptor radionuclide therapy with [¹⁷⁷Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma

    • Noémie S. Minczeles
    • Eelke M. Bos
    • Tessa Brabander

    Original Article 01 December 2022 Pages: 1195 - 1204

    

20. [¹⁸F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[¹⁸F]FDG PET/CT

    • Xingyu Mu
    • Xiaoxue Huang
    • Jingsong Mao

    Original Article Open access 10 December 2022 Pages: 1205 - 1215

    

21. [⁶⁸Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques

    • Ankit Watts
    • Baljinder Singh
    • Digambar Behera

    Original Article 09 December 2022 Pages: 1216 - 1227

    

22. The role of [^99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience

    • Xi Jia
    • Xinru Li
    • Rui Gao

    Original Article Open access 07 December 2022 Pages: 1228 - 1239

    

23. Head-to-head comparisons of [⁶⁸Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study

    • Zhi-Bin Ke
    • Shao-Ming Chen
    • Ning Xu

    Original Article 22 November 2022 Pages: 1240 - 1251

    

24. Tumor lesion detection in patients with cervical cancer by indocyanine green near-infrared imaging

    • Pengfei Li
    • Jiaqi Liu
    • Chunlin Chen

    Original Article 01 December 2022 Pages: 1252 - 1261

    

25. Three-way multiplexing in prostate cancer patients — combining a bimodal sentinel node tracer with multicolor fluorescence imaging

    • Anne-Claire Berrens
    • Matthias N. van Oosterom
    • Tessa Buckle

    Image of the Month Open access 19 November 2022 Pages: 1262 - 1263

    

26. Advanced imaging findings in stroke-like migraine attacks after radiation therapy (SMART) syndrome

    • Nico Teske
    • Nathalie L. Albert
    • Philipp Karschnia

    Image of the Month Open access 23 November 2022 Pages: 1264 - 1265

    

27. [¹⁷⁷Lu]Lu-FAP-2286 therapy in a case of right lung squamous cell carcinoma with systemic metastases

    • Zijuan Rao
    • Yu Zhang
    • Chunyin Zhang

    Image of the Month 24 November 2022 Pages: 1266 - 1267

    

28. Active uptake of [¹⁸F]F-FAPI-42 in eosinophilic gastrointestinal disorder

    • Lilan Fu
    • Wenlan Zhou

    Image of the Month 01 December 2022 Pages: 1268 - 1269

    

29. Neurexin-3α-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET/MRI

    • Chenpeng Zhang
    • Yong Hao
    • Jianjun Liu

    Image of the Month 06 December 2022 Pages: 1270 - 1272

    

30. Correction to: Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [¹⁸F]MK6240 in human subjects

    • Nicolas J. Guehl
    • Dustin W. Wooten
    • Marc D. Normandin

    Correction 05 January 2023 Pages: 1273 - 1273